Promis Neurosciences Inc (PMN)

Jan 29, 2025

StockNews.com Initiates Coverage on Beasley Broadcast Group (NASDAQ:BBGI) - Defense World

Jan 29, 2025

Jan 29, 2025

Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference - The Manila Times

Jan 29, 2025

Jan 29, 2025

ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Jan 29, 2025

Jan 29, 2025

ProMIS Neurosciences Updates Corporate Presentation in Recent 8-K Filing - Defense World

Jan 29, 2025

Jan 29, 2025

Vanda Pharmaceuticals Files for New Drug Application for Tradipitant for Motion Sickness Treatment - Defense World

Jan 29, 2025

Jan 27, 2025

ProMIS Neurosciences Highlights Neurodegenerative Disease Focus - TipRanks

Jan 27, 2025

Jan 20, 2025

ProMIS Neurosciences launch Phase Ia AβO Alzheimer’s trial - MSN

Jan 20, 2025

Jan 13, 2025

ProMIS Neurosciences Issues Letter to Shareholders - Markets Insider

Jan 13, 2025

Jan 11, 2025

Crude Oil WTI (CLN25) Quote - The Globe and Mail

Jan 11, 2025

Jan 10, 2025

Crude Oil Brent (F) (QAJ23) Quote - The Globe and Mail

Jan 10, 2025

Jan 10, 2025

ProMIS Neurosciences Launches Phase 1b Trial for Alzheimer’s - TipRanks

Jan 10, 2025

Jan 10, 2025

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer's Disease - The Manila Times

Jan 10, 2025

Jan 10, 2025

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones - The Manila Times

Jan 10, 2025

Jan 10, 2025

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease - GlobeNewswire

Jan 10, 2025

Jan 09, 2025

ProMIS Neurosciences faces Nasdaq delisting over share price - Investing.com

Jan 09, 2025

Jan 02, 2025

Nonfat Dry Milk (DFZ25) Quote - The Globe and Mail

Jan 02, 2025

Dec 27, 2024

Berkshire Hathaway Cl B (BRK-B-N) QuotePress Release - The Globe and Mail

Dec 27, 2024

Dec 27, 2024

ProMIS Neurosciences (NASDAQ:PMN) Shares Up 2.8% – Should You Buy? - Defense World

Dec 27, 2024

Dec 19, 2024

ProMIS Neurosciences stock hits 52-week low at $0.88 By Investing.com - Investing.com Nigeria

Dec 19, 2024

Dec 18, 2024

ProMIS Neurosciences stock hits 52-week low at $0.88 - Investing.com

Dec 18, 2024

Dec 06, 2024

Vertiv Holdings Llc. (VRT-N) QuotePress Release - The Globe and Mail

Dec 06, 2024

Dec 02, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN) Short Interest Down 16.6% in November - Defense World

Dec 02, 2024

Nov 26, 2024

ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference - GlobeNewswire

Nov 26, 2024

Nov 20, 2024

ProMIS Neurosciences stock hits 52-week low at $0.91 - Investing.com

Nov 20, 2024

Nov 20, 2024

ProMIS Neurosciences stock hits 52-week low at $0.91 By Investing.com - Investing.com Australia

Nov 20, 2024

Nov 16, 2024

ProMIS Neurosciences Announces Third Quarter Financial Results and Recent HighlightsOn November 14, 2024, ProMIS Neurosciences Inc. (Nasdaq: PMN) shared its financial outcomes for the third quarter ended September 30, 2024. The company provide - Defense World

Nov 16, 2024

Nov 15, 2024

ProMIS Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

GREAT POINT PARTNERS LLC Acquires Shares in ProMIS Neurosciences Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

ProMIS Neurosciences Inc (PMN) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in ProMIS Neurosciences Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

ProMIS Neurosciences Inc Reports Q3 2024 GAAP EPS of $0.31, Surp - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

ProMIS Reports Positive Phase 1a Results for Alzheimer's Drug, Secures $30.3M Financing | PMN Stock News - StockTitan

Nov 14, 2024

Nov 12, 2024

ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - GlobeNewswire

Nov 12, 2024

Nov 11, 2024

'Animal spirits' set to drive S&P 500 to 6,600 by mid-2025, Evercore says - Investing.com

Nov 11, 2024

Nov 08, 2024

Rising Revenue & Strategic Pipeline Advances Propel Biotech Growth Trajectory - Streetwise Reports

Nov 08, 2024

Nov 07, 2024

New Blood Cancer Treatment Shows Continued Response - Streetwise Reports

Nov 07, 2024

Nov 06, 2024

ProMIS Neurosciences (STU:23J0) PensionAndRetirementBenefit : €0.43 Mil (As of Jun. 2024) - GuruFocus.com

Nov 06, 2024

Oct 31, 2024

Biotech Shares Positive Phase I Data for Alzheimer's Treatment - Streetwise Reports

Oct 31, 2024

Oct 30, 2024

ProMIS Neurosciences Presents Positive Data from PMN310 - GlobeNewswire

Oct 30, 2024

Oct 30, 2024

ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference - StockTitan

Oct 30, 2024

Oct 28, 2024

Boston Biotech Announces Novartis Collaboration - Streetwise Reports

Oct 28, 2024

Oct 24, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN): Among The 10 Oversold Canadian Stocks to Buy Right Now - Insider Monkey

Oct 24, 2024

Oct 23, 2024

10 Oversold Canadian Stocks to Buy Right Now - Insider Monkey

Oct 23, 2024

Oct 22, 2024

ProMIS Neurosciences stock hits 52-week low at $0.92 - Investing.com India

Oct 22, 2024

Oct 21, 2024

ProMIS Neurosciences stock hits 52-week low at $0.92 By Investing.com - Investing.com South Africa

Oct 21, 2024